Atea Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -104 | -104 | -38,234 |
EBITDA | -45,286 | -51,531 | -41,749 |
EBIT | -45,390 | -51,635 | -41,853 |
Net Income | -45,440 | -44,867 | -42,049 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -46,391 | -28,223 | -40,375 |
Cash | 79,317 | 95,713 | 77,344 |
Basic Shares | 79,198 | 78,126 | 79,052 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $192,180 |
Gross Profit | -416 | -83,367 | -70,090 | -260 |
EBITDA | -164,095 | -131,800 | -119,593 | -130,390 |
EBIT | -164,511 | -132,216 | -120,009 | -130,650 |
Net Income | -158,349 | -168,385 | -135,956 | -115,909 |
Net Change In Cash | 0 | 0 | 0 | 192,180 |
Free Cash Flow | -132,031 | -135,499 | -85,395 | -122,925 |
Cash | 95,713 | 64,696 | 143,823 | 646,709 |
Basic Shares | 81,495 | 84,264 | 83,389 | 83,245 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.41 |
2026-03-31 | -$0.57 |
2025-12-31 | -$0.57 |
2025-09-30 | -$0.53 |